Upcoming Allied Market Research
Flowable Hemostats Market

Flowable Hemostats Market

by Application (General Surgery, Cardiac Surgery, Vascular Surgery, Neuro & Spine Surgery, Orthopedic Surgery, and Others), Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A12649
Pages: NA
Nov 2022 | 839 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Flowable Hemostats Market

Request Now !

Rise in the prevalence of bleeding disorders has paved the way for design, development, and piloting of flowable hemostats. Operative bleeding in the hospitals can lead to prolonged bleeding complications.  To counter this, various kinds of hemostat products such as gelatin-based, collagens, fibrin sealants, active thrombin preparations are applied to reduce the amount of prolonged blood flow from the body. If not countered, prolonged bleeding can lead to increased risk of infections, increased mortality, and unstable hemodynamics. Among different kinds of hemostat products, flowable hemostat are most commonly used, which consist of a thick consistency and contain bovine matrix. More importantly, flowable hemostats can be used for all kinds of surgeries such as cardio and vascular, except ophthalmic surgeries.

Market Scope and Structure Analysis

Report Metric


 Market Size Available for Years


 Base Year Considered


 Forecast Period


 Forecast Unit

 Value (USD)

 Segments Covered

 Application, Product, Material, End User, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Baxter International, Stryker Corporation, Cryolife, Inc., Becton, Dickson & Company, Medtronic Ltd., Johnson & Johnson Services, Pfizer, Integra LifeSciences Corporation, Biom’up Ltd., Ethicon LLC., BD Ltd, Gelita Medical, C.R.Bard Inc, Z-Medica Inc, Teleflex Incorporated, Arch Therapeutics Ltd.


COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the flowable hemostats market.

Top Impacting Factors

  • Pre-hospital hemorrhage cases are rising around the globe, which have fueled the demand for thrombin-gelatin based hemostatic matrix in devices.
  • There is a huge demand for hemostats that have capabilities to deploy effective hemostasis in cases of surgical removal of splenic mass to reduce post-operative conditions associated.
  • Rising global trauma incidents and frequent fatal accidents are driving the demand for development of alternative techniques to manage pre and post-operative bleeding. This, in turn, is driving growth of flowable hemostat market.
  • Underlying need for design and development of alternative mechanisms against use of surgical needles is driving the demand for flowable hemostats as an effective blood controlling agent in vascular sites.
  • In the countries with large defense spending and intense battlefields such as India, China, and the U.S., there is a growing need and support from the central government to design ways to help soldiers in cases of battle emergencies such as blood control, post battle trauma, and cardiovascular impacts. This, in turn, is driving growth of flowable hemostats market.
  • Additionally, lack of awareness regarding bleeding and related in low- & middle-income economies hampers the market growth.

Key Market Trends

  • North America is anticipated to gain significant gains, owing to rise of bleeding disorders and increase in accidents and post traumas across the region coupled with need for advanced mechanisms to replace traditional surgical needles and related devices.
  • Baxter International, a leading player in healthcare manufacturing industry, launched FLOSEAL Hemostatic Matrix in contrast to traditional micro porous polysaccharide powder materials as an effective flowable hemostatic alternative in the market.
  • Teleflex Ltd. launched its own made clinically backed D-Stat flowable hemostat to reduce incidents of hemotoma formation in pulse generating implants.
  • Mergers and Acquisitions are part of the growing industry, and in one such instance in 2019, Baxtor International acquired two flowable hemostat products from Mallinckrodt, RECOTHROM and PREVELEAK, both of which are used for cardiovascular reformations/reconstructions.

Key Segments Covered




  • General Surgery
  •  Cardiac Surgery
  •  Vascular Surgery
  •  Neuro & Spine Surgery
  •  Orthopedic Surgery
  •  Others


  • Porcine Gelatin
  •  Bovine Gelatin


  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • Others

 End User

  • Hospitals
  •  Clinics
  •  Diagnostic Laboratories
  •  Ambulatory Surgery Centers
  •  Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Benefits of the Report

  • This study presents the analytical depiction of the flowable hemostats industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Flowable Hemostats Report

  • Which are the leading players active in the flowable hemostats market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the flowable hemostats market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is flowable hemostats?
  • What is the flowable hemostats market prediction in the future?
  • What are the current trends and predicted trends?

Flowable Hemostats Market Report Highlights

Aspects Details
By Application
  • General Surgery      
  • Cardiac Surgery
  • Vascular Surgery
  •  Neuro and Spine Surgery
  • Orthopedic Surgery
  •  Others
By Material
  • Porcine Gelatin  
  • Bovine Gelatin
By Product
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • Others
By End User
  • Hospitals    
  • Clinics
  •  Diagnostic Laboratories
  • Ambulatory Surgery Centers  
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Baxter International, Stryker Corporation, Cryolife, Inc., Becton, Dickson and Company, Medtronic Ltd., Johnson and Johnson Services, Pfizer Inc., Integra LifeSciences Corporation, Teleflex Incorporated, Arch Therapeutics Ltd.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now









Purchase Full Report of
Flowable Hemostats Market

Start reading.
This Report and over 18,881+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers